skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Monoamine oxidase: Radiotracer chemistry and human studies

Journal Article · · Journal of Labelled Compounds and Radiopharmaceuticals
DOI:https://doi.org/10.1002/jlcr.3247· OSTI ID:1183290
 [1];  [2];  [3];  [4];  [3];  [5]
  1. Brookhaven National Lab. (BNL), Upton, NY (United States)
  2. New York Univ., Langone Medical Center, New York, NY (United States)
  3. National Inst. on Alcohol Abuse and Alcoholism, National Inst. of Health, Betheseda, MD (United States)
  4. Mount Sinai School of Medicine, New York, NY (United States)
  5. National Inst. on Alcohol Abuse and Alcoholism, National Inst. of Health, Betheseda, MD (United States); National Inst. on Drug Abuse, National Inst. of Health, Bethesda, MD (United States)

Monoamine oxidase (MAO) oxidizes amines from both endogenous and exogenous sources thereby regulating the concentration of neurotransmitter amines such as serot onin, norepinephrine and dopamine as well as many xenobiotics. MAO inhibitor drugs are used in the treatment of Parkinson’s disease and in depression stimulating the development of radiotracer tools to probe the role of MAO in normal human biology and in disease. Over the past 30 since the first radiotracers were developed and the first PET images of MAO in humans were carried out, PET studies of brain MAO in healthy volunteers and in patients have identified different variables which have contributed to different MAO levels in brain and in peripheral organs. MAO radiotracers and PET have also been used to study the current and developing MAO inhibitor drugs including the selection of doses for clinical trials. In this article, we describe (1) the development of MAO radiotracers; (2) human studies including the relationship of brain MAO levels to genotype, personality, neurological and psychiatric disorders; (3) examples of the use of MAO radiotracers in drug research and development. We will conclude with outstanding needs to improve the radiotracers which are currently used and possible new applications.

Research Organization:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
SC00112704
OSTI ID:
1183290
Report Number(s):
BNL-107778-2015-JA; R&D Project: MO-085; KP1602010
Journal Information:
Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 58, Issue 3; ISSN 0362-4803
Publisher:
WileyCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 40 works
Citation information provided by
Web of Science

References (92)

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release journal August 2014
Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications journal January 2014
Deuterium Isotope Effects in Relation to the Chemical Mechanism of Monoamine Oxidase* journal July 1963
Localization of monoamine oxidases in human peripheral tissues journal September 1996
Monoamine Oxidase in Neuropsychiatry and Behavior journal September 1999
Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression journal August 2013
Selective inhibitors of monoamine oxidase type B and the “cheese effect” book January 2011
Monoamine oxidase: radiotracer development and human studies journal July 2002
Translational Neuroimaging: Positron Emission Tomography Studies of Monoamine Oxidase journal November 2005
Radiochemistry devoted to the production of monoamine oxidase (MAO-A and MAO-B) ligands for brain imaging with positron emission tomography: Radiochemistry devoted to the production of MAO PET ligands journal March 2013
Evaluation of radiorespirometry for the determination of monoamine oxidase activity in vivo utilizing [11c]octylamine as a substrate journal October 1977
Synthesis of suicide inhibitors of monoamine oxidase: Carbon-11 labeled clorgyline, L-deprenyl and D-deprenyl journal January 1988
Species differences in [ 11 C]clorgyline binding in brain journal October 2001
New insights into the structures and functions of human monoamine oxidases A and B journal March 2007
Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: Potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography journal September 1985
Mechanistic Positron Emission Tomography Studies: Demonstration of a Deuterium Isotope Effect in the Monoamine Oxidase-Catalyzed Binding of [ 11 C]l-Deprenyl in Living Baboon Brain journal November 1988
Synthesis of Some 11C-Labelled MAO-A Inhibitors and Their In Vivo Uptake Kinetics in Rhesus Monkey Brain journal July 1997
Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET journal January 1987
Non-MAO A binding of clorgyline in white matter in human brain: Non-MAO a binding of clorgyline in white matter journal November 2001
Strategy for the Formation of Parametric Images Under Conditions of Low Injected Radioactivity Applied to PET Studies With the Irreversible Monoamine Oxidase A Tracers [11C]Clorgyline and Deuterium-Substituted [11C]Clorgyline journal November 2002
Monoamine oxidase A imaging in peripheral organs in healthy human subjects journal May 2003
Graphical analysis of PET data applied to reversible and irreversible tracers journal October 2000
Distribution of Monoamine Oxidase Proteins in Human Brain: Implications for Brain Imaging Studies journal February 2013
Radioactive N,N-Dimethylphenylethylamine: A Selective Radiotracer for In Vivo Measurement of Monoamine Oxidase-B Activity in the Brain journal January 1985
11C-labelling of dimethylphenethylamine in two different positions and biodistribution studies
  • Halldin, Christer; Bjurling, Peter; Stålnacke, Carl-Göran
  • International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, Vol. 40, Issue 7 https://doi.org/10.1016/0883-2889(89)90108-1
journal January 1989
11C-harmine as a tracer for monoamine oxidase a (MAO-A): In vitro and in vivo studies journal May 1997
MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography journal April 1997
Positron Emission Tomography Quantification of [ 11 C]-Harmine Binding to Monoamine Oxidase-A in the Human Brain journal August 2005
Dynamic, Adaptive Changes in MAO-A Binding after Alterations in Substrate Availability: An in vivo [ 11 C]-Harmine Positron Emission Tomography Study journal December 2011
Efficient synthesis of [ 11 C]befloxatone, a selective radioligand for the in vivo imaging of MAO-A density using PET : EFFICIENT SYNTHESIS OF [ journal May 2003
Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [ 11 C]Befloxatone journal February 2003
Design, Synthesis, and Biological Activities of Pyrrolylethanoneamine Derivatives, a Novel Class of Monoamine Oxidases Inhibitors journal June 2005
Synthesis and Cerebral Uptake of 1-(1-[ 11 C]Methyl-1 H -pyrrol-2-yl)-2-phenyl-2-(1-pyrrolidinyl)ethanone, a Novel Tracer for Positron Emission Tomography Studies of Monoamine Oxidase Type A journal March 2008
Radiosynthesis of (S)-5-methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl] oxazolidin-2-[11C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET journal January 2008
[ 11 C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: Preclinical characterisation in nonhuman primate journal January 2010
Radiosynthesis of [11C]SL25.1188 via [11C]CO2 fixation for imaging monoamine oxidase B journal July 2011
Kinetic Modeling of the Monoamine Oxidase B Radioligand [ 11 C]SL25.1188 in Human Brain with High-Resolution Positron Emission Tomography journal February 2014
[ 11 C]Befloxatone Distribution is well Correlated to Monoamine Oxidase a Protein Levels in the Human Brain journal September 2014
Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl, (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and PET studies in baboon brain journal July 1990
The synthesis of no-c arrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction
  • Plenevaux, Alain; Fowler, Joanna S.; Dewey, Stephen L.
  • International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, Vol. 42, Issue 2 https://doi.org/10.1016/0883-2889(91)90060-E
journal January 1991
N-(6-18F-Fluorohexyl)-N-Methylpropargylamine: A Fluorine-18-Labeled Monoamine Oxidase B Inhibitor for Potential Use in PET Studies journal January 1999
Development of new radiopharmaceuticals for imaging monoamine oxidase B journal October 2011
Synthesis of Three Novel Fluorine-18 Labeled Analogues of l -Deprenyl for Positron Emission Tomography (PET) studies of Monoamine Oxidase B (MAO-B) journal October 2011
In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO-B pet radioligand journal December 2011
Synthesis and evaluation of [18F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B) journal May 2012
Development of a novel fluorine-18 labeled deuterated fluororasagiline ([18F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B) journal November 2013
Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity journal January 2013
Synthesis of fluorine and iodine analogues of clorgyline and selective inhibition of monoamine oxidase A. journal January 1991
Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A journal October 1993
A functional polymorphism in the monoamine oxidase A gene promoter journal September 1998
Role of Genotype in the Cycle of Violence in Maltreated Children journal August 2002
Neurobiological Mechanisms for Impulsive-Aggression: The Role of MAOA book January 2013
Evidence That Brain MAO A Activity Does Not Correspond to MAO A Genotype in Healthy Male Subjects journal August 2007
Evidence that the methylation state of the monoamine oxidase A ( MAOA ) gene predicts brain activity of MAO A enzyme in healthy men journal October 2012
GeMes, Clusters of DNA Methylation under Genetic Control, Can Inform Genetic and Epigenetic Analysis of Disease journal April 2014
Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits journal September 2010
Monoamine Oxidase and Cigarette Smoking journal January 2003
Brain monoamine oxidase A inhibition in cigarette smokers journal November 1996
Inhibition of monoamine oxidase B in the brains of smokers journal February 1996
An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo journal June 1998
Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers journal December 1999
Maintenance of Brain Monoamine Oxidase B Inhibition in Smokers After Overnight Cigarette Abstinence journal November 2000
Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone journal January 2009
Low monoamine oxidase B in peripheral organs in smokers journal September 2003
Monoamine Oxidase A Binding in the Prefrontal and Anterior Cingulate Cortices During Acute Withdrawal From Heavy Cigarette Smoking journal August 2011
Elevated Monoamine Oxidase A Levels in the Brain: An Explanation for the Monoamine Imbalance of Major Depression journal November 2006
Greater Monoamine Oxidase A Binding in Alcohol Dependence journal May 2014
Neocortical cell counts in normal human adult aging journal June 1987
Age-Related Increases in Brain Monoamine Oxidase B in Living Healthy Human Subjects journal July 1997
Positron Emission Tomography with [11C]Deuterium-Deprenyl in Temporal Lobe Epilepsy journal July 1995
PET with 11 C-deuterium-deprenyl and 18 F-FDG in focal epilepsy journal June 2001
Comparison of Brain Glucose Metabolism and Monoamine Oxidase B (MAO B) in Traumatic Brain Injury journal March 1999
Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET journal April 2007
Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease journal January 2003
Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-l-deprenyl using whole hemisphere autoradiography journal January 2011
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG journal January 2012
In Vivo Molecular Imaging Biomarkers: Clinical Pharmacology’s new “PET”? journal June 2007
Monoamine oxidase A and B substrates: probing the pathway for drug development journal April 2014
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327 journal February 1991
Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: The degree and reversibility of human brain MAO B inhibition by Ro 19 6327 journal October 1993
Slow recovery of human brain MAO B after L-Deprenyl (Selegeline) withdrawal journal October 1994
Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l-[ 11 C]Deprenyl journal August 1987
Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography journal September 1994
Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301 journal January 2009
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study journal November 2011
Extracts of ginkgo biloba leaves inhibit monoamine oxidase journal March 1996
Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157 journal November 2009
Drug Delivery in the Twenty-First Century: A New Paradigm journal May 2009
Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis journal May 2014
Monoamine oxidase B activity is increased in human gliomas journal January 2008
Suicide enzyme inactivators journal September 1976
Comparison of the binding of the irreversible monoamine oxidase tracers, [11C]clorgyline and [11C]l-deprenyl in brain and peripheral organs in humans journal April 2004

Cited By (9)

Synthesis and characterization of novel radiofluorinated probes for positron emission tomography imaging of monoamine oxidase B journal July 2019
Kinetics, mechanism, and inhibition of monoamine oxidase journal March 2018
The monoamine oxidase inhibition properties of C6- and N1-substituted 3-methyl-3,4-dihydroquinazolin-2(1H)-one derivatives journal May 2019
Neuroinflammation in Neurodegenerative Disorders—a Review journal March 2017
Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity journal January 2017
Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy journal June 2018
Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration journal August 2016
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs journal July 2017
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs journal July 2017